Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Y4PL
|
|||
Former ID |
DIB014572
|
|||
Drug Name |
QAP-642
|
|||
Synonyms |
CCR3 antagonist (allergic rhinitis), Novartis
Click to Show/Hide
|
|||
Indication | Allergic rhinitis [ICD-11: CA08.0] | Terminated | [1] | |
Company |
Novartis AG
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | C-C chemokine receptor type 3 (CCR3) | Target Info | Antagonist | [2] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Chemokine signaling pathway | ||||
Viral carcinogenesis | ||||
NetPath Pathway | IL3 Signaling Pathway | |||
Panther Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | |||
Reactome | Chemokine receptors bind chemokines | |||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
IL1 and megakaryotyces in obesity | ||||
IL-3 Signaling Pathway | ||||
Peptide GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023202) | |||
REF 2 | New Drugs and Targets for Asthma and COPD. T.T. Hansel, P.J. Barnes. 2010. Page 158. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.